Level C· Early human research exploring benefitsCohort StudyPubMedOpen access

C-C chemokine ligand 5 from women subcutaneous adipose tissue has a central role in vascular aging.

Le Pelletier L., Ngono Ayissi K., Gorwood J., Capel E., Morichon R., Mantecon M.

Cohort Study on Systemic / IV, published in Cardiovasc Diabetol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
Cardiovasc Diabetol (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40682056
PMCID
PMC12275387
DOI
10.1186/s12933-025-02815-4
NCT
NCT01420523

Abstract (original English)

BACKGROUND: Aging is associated with adipose tissue alterations, oxidative stress, and fibrosis and the onset of cardiometabolic complications. While it has been shown that perivascular adipose tissue (PVAT) contributes to vascular damage, the involvement of subcutaneous adipose tissue (SCAT) - particularly through its secretory activity - in vascular aging remains poorly understood. Previously, we have demonstrated that human adipose-derived stromal cells (ASCs) from the SCAT of aged women display senescence and oxidative stress. We hypothesized that the ASC secretome contributes to the onset of endothelial dysfunction, an early stage of vascular aging. METHODS: We prepared conditioned media from ASCs isolated from SCAT of healthy young (< 25y) or aged (> 60y) women. The ASCs secretome was analyzed and added on human coronary artery endothelial cells (HCAECs). Using clinical cohorts, we evaluated the expression of C-C-chemokine-ligand-5 (CCL5)/Regulated upon-Activation-Normally-T-expressed-and-secreted (RANTES) in adipose tissue of individuals with coronary heart disease. RESULTS: The secretome of aged-donor ASCs induced endothelial cell dysfunction in HCAEC, as evidenced by lower nitric oxide production, higher oxidative stress, senescence, and a pro-adherent phenotype. Aged-donor ASCs also favored the endothelial-to-mesenchymal transition, characterized by the higher express

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansChemokine CCL5FemaleSubcutaneous FatMiddle AgedEndothelial CellsCells, CulturedCellular SenescenceAdultOxidative Stress

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research